Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-03-25 | His substantial and varied experience as an executive of an international, public company, including working closely with the board of directors of Monsanto, brings significant insight into functional areas critical to Eastman. |
| 2016-03-23 | His substantial and varied experience as an executive of an international, public company, including working closely with the board of directors of Monsanto, brings to the Board significant depth of knowledge and experience in global biotechnology and chemicals business operations. |
| 2017-03-23 | His substantial and varied experience as an executive of an international, public company, including working closely with the Board of Directors of Monsanto, brings to the Board a significant depth of knowledge and experience in global biotechnology and chemicals business operations. |
| 2018-03-22 | His substantial and varied experience as an executive of an international public company, including working closely with the Board of Directors of Monsanto, brings to the Board a significant depth of knowledge and experience in global biotechnology and chemicals business operations and international and emerging markets growth strategies. |
| 2019-03-22 | His wide-ranging experience and knowledge contributes to the Board and its Committees significant insight into a number of functional areas critical to Eastman, including as Chair of the Compensation and Management Development Committee. |
| 2020-03-25 | His substantial and varied experience as an executive of an international public company, including working closely with the Board of Directors of Monsanto and the Supervisory Board and the Board of Management of Bayer, brings significant depth of knowledge and experience in global biotechnology and chemicals business operations. |
| 2021-03-25 | His wide-ranging experience and knowledge contributes to the Board and its Committees significant insight into a number of functional areas critical to Eastman, including as Chair of the Compensation and Management Development Committee. |
| 2022-03-23 | His wide-ranging experience and knowledge contributes to the Board and its Committees significant insight into a number of functional areas critical to Eastman, including as Chair of the Compensation and Management Development Committee. |
| 2023-03-22 | Mr. Begemann’s substantial and varied experience as an executive of an international public company, including working closely with the Board of Directors of Monsanto and the Supervisory Board and the Board of Management of Bayer, brings to the Board a significant depth of knowledge and experience in global biotechnology and chemicals business operations and international and emerging markets growth strategies, and public company management development and compensation, and risk management. |
| 2024-03-21 | Mr. Begemann’s substantial and varied experience as an executive of an international public company brings to the Board a significant depth of knowledge in global biotechnology and chemicals businesses. |
| 2025-03-21 | Retired Chief Operating Officer of Crop Science Division of Bayer AG; Brings global biotechnology and chemicals business operations insights. |
Data sourced from SEC filings. Last updated: 2025-10-12